Targeting the Canonical Nuclear Factor-κB Pathway With a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2017.01.083
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Corynebacterium Tuberculostearicum , a Human Skin Colonizer, Induce the Canonical Nuclear Factor‐κB Inflammatory Signaling Pathway in the Human Skin Cells

Immunity, inflammation and disease
AllergyImmunology
2020English

Thrombin Down-Regulates Tissue Factor Pathway Inhibitor Expression in a PI3K/Nuclear Factor-κB–Dependent Manner in Human Pleural Mesothelial Cells

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2015English

Inhibition of Hepatocyte Nuclear Factor 4 Transcriptional Activity by the Nuclear Factor κB Pathway

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2006English

Regulation of the Nuclear Factor (NF)-κB Pathway by ISGylation

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2008English

Comprehensive Evaluation of a Novel Nuclear Factor-κB Inhibitor, Quinoclamine, by Transcriptomic Analysis

British Journal of Pharmacology
Pharmacology
2009English

Nuclear Factor-κB and Inhibitor of κB Kinase Pathways in Oncogenic Initiation and Progression

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Non-Canonical NF-κB Signaling Pathway

Cell Research
Cell BiologyMolecular Biology
2010English

Combined Treatment With a Transforming Growth Factor Beta Inhibitor (1D11) and Bortezomib Improves Bone Architecture in a Mouse Model of Myeloma-Induced Bone Disease

Bone
EndocrinologyPhysiologyHistologyMetabolismDiabetes
2016English

Neuroglobin Overexpression Improves Sensorimotor Outcomes in a Mouse Model of Traumatic Brain Injury

Neuroscience Letters
Neuroscience
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy